Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Biodesix (BDSX) Long-Term Debt Issuances (2019 - 2022)

Biodesix (BDSX) has disclosed Long-Term Debt Issuances for 4 consecutive years, with $30.0 million as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Long-Term Debt Issuances changed N/A year-over-year to $30.0 million, compared with a TTM value of $30.0 million through Dec 2025, changed N/A, and an annual FY2025 reading of $10.0 million, changed N/A over the prior year.
  • Long-Term Debt Issuances was $30.0 million for Q4 2022 at Biodesix, up from $15.0 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $30.0 million in Q1 2021 and bottomed at -$9.9 million in Q3 2020.
  • Average Long-Term Debt Issuances over 4 years is $9.0 million, with a median of $6.4 million recorded in 2020.
  • Peak annual rise in Long-Term Debt Issuances hit 19129.49% in 2022, while the deepest fall reached 99.66% in 2022.
  • Year by year, Long-Term Debt Issuances stood at $3.0 million in 2019, then tumbled by 424.24% to -$9.9 million in 2020, then surged by 100.79% to $78000.0 in 2021, then soared by 38361.54% to $30.0 million in 2022.
  • Business Quant data shows Long-Term Debt Issuances for BDSX at $30.0 million in Q4 2022, $15.0 million in Q2 2022, and $103000.0 in Q1 2022.